SAMSARA BIOCAPITAL, LLC

PALO ALTO, CA · CIK 1744967 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2018 · limited liability company

Assets managed$2.2bn
Staff31 · 22 in investment roles
Main clients (by assets)Private funds 100%
Private funds3 · $2.3bn gross assets
Websitesamsaracap.com
Form ADV · 2026-06-26SEC adviser record

Kindventure
Others nearbyPalo Alto, CA

As an employer

Private fundsventure capital 3

US visa salary filings

Filings FY20242
Median salary offered$187,500
Middle half$181,250 – $193,750
Job titles1

Job title	Filings	Median	Range
Senior AssociatePalo Alto, CA	2	$187,500	$175,000 – $200,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.

$1.2bn reported value +18.3% vs Q1 2026

24positions

90.5%in top 10

4 new 2 added 5 reduced 2 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	SCHOLAR ROCK HLDG CORP COM SRRK	SRRK	6,897,652	$379.4m31.16%	31.16%	Unchanged
2	ALUMIS INC COM ALMS	ALMS	6,345,219	$178.6m14.67%	14.67%	Unchanged
3	MINERALYS THERAPEUTICS INC COM MLYS	MLYS	5,871,018	$158.4m13.01%	13.01%	Unchanged
4	SEPTERNA INC COM SEPN	SEPN	3,149,128	$105.5m8.66%	8.66%	Unchanged
5	ALAMAR BIOSCIENCES INC COMMON STOCK ALMR	ALMR	2,480,310	$67.2m5.52%	5.52%	New
6	NEUROGENE INC COM NGNE	NGNE	1,717,127	$54.0m4.44%	4.44%	Unchanged
7	KALARIS THERAPEUTICS INC COM KLRS	KLRS	12,881,175	$52.4m4.31%	4.31%	Reduced -66.9k	-66,906 -0.5%
8	SPYGLASS PHARMA INC COM SHS SGP	SGP	2,109,953	$47.0m3.86%	3.86%	Unchanged
9	SUTRO BIOPHARMA INC COM SHS STRO	STRO	1,062,872	$35.3m2.90%	2.90%	Unchanged
10	INVENTIVA SA ADS IVA	IVA	6,314,805	$23.9m1.96%	1.96%	Added +1.1m	+1,120,000 21.6%
11	JADE BIOSCIENCES INC COM NEW JBIO	JBIO	736,237	$16.4m1.34%	1.34%	Reduced -232.6k	-232,561 -24.0%
12	PARABILIS MEDICINES INC COM PBLS	PBLS	556,044	$15.2m1.25%	1.25%	New
13	VTV THERAPEUTICS INC CL A NEW VTVT	VTVT	298,496	$11.2m0.92%	0.92%	Unchanged
14	AQUESTIVE THERAPEUTICS INC COM AQST	AQST	2,500,000	$10.4m0.85%	0.85%	Unchanged
15	NKARTA INC COM NKTX	NKTX	3,507,666	$9.9m0.82%	0.82%	Unchanged
16	ARTIVA BIOTHERAPEUTICS INC COM ARTV	ARTV	954,861	$9.3m0.76%	0.76%	New
17	RANI THERAPEUTICS HLDGS INC COM CL A RANI	RANI	10,369,159	$7.9m0.65%	0.65%	Added +1.9m	+1,869,159 22.0%
18	AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB	AGMB	600,000	$7.8m0.64%	0.64%	Unchanged
19	ABIVAX SA SPONSORED ADS ABVX	ABVX	55,095	$7.3m0.60%	0.60%	Reduced -1.5k	-1,486 -2.6%
20	X4 PHARMACEUTICALS INC COM NEW XFOR	XFOR	1,395,587	$6.5m0.54%	0.54%	Reduced -437.0k	-436,979 -23.9%
21	ELOXX PHARMACEUTICALS INC COM NEW ELOX	ELOX	400,000	$5.6m0.46%	0.46%	New
22	COHERUS BIOSCIENCES INC COM CHRS	CHRS	3,428,571	$4.8m0.39%	0.39%	Unchanged
23	UPSTREAM BIO INC COM UPB	UPB	353,717	$2.4m0.20%	0.20%	Reduced -382.3k	-382,330 -51.9%
24	GOSSAMER BIO INC COM GOSS	GOSS	7,222,559	$1.2m0.10%	0.10%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
ARCELLX INC ACLX	ACLX	60,873	$7.0m60.9k shares
PALVELLA THERAPEUTICS INC NE PVLA	PVLA	38,432	$4.8m38.4k shares